Qualcomm — Nov 6, 2024 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000804328-24-000074
Showing in the filing
Revenues
“$10.5B - $11.3B”
Period
Q1 FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 8
New stock repurchase authorization
“$15.0 billion”
Revenues for Q1 FY2025
“$10.5B - $11.3B”
QCT revenues for Q1 FY2025
“$9.0B - $9.6B”
QTL revenues for Q1 FY2025
“$1.45B - $1.65B”
GAAP diluted EPS for Q1 FY2025
“$2.39 - $2.59”
Less diluted EPS attributable to share-based… for Q1 FY2025
“($0.53)”
Less diluted EPS attributable to other items for Q1 FY2025
“$0.07”
Non-GAAP diluted EPS for Q1 FY2025
“$2.85 - $3.05”
Exhibit 99.1 · the passage around this item
… earlier in the release
The “Note Regarding Forward-Looking Statements” in this news release provides a description of certain risks that we face, and our most recent annual report on file with the Securities and Exchange Commission (SEC) provides a more complete description of our risks. The following table summarizes GAAP and Non-GAAP guidance based on the current outlook. Current Guidance Q1 FY25 Estimates 1 Revenues $10.5B - $11.3B Supplemental Revenue Information QCT revenues $9.0B - $9.6B QTL revenues $1.45B - $1.65B GAAP diluted EPS $2.39 - $2.59 Less diluted EPS attributable to QSI $— Less diluted EPS attributable to share-based compensation ($0.53) Less diluted EPS attributable to other items 2 $0.07 Non-GAAP diluted EPS $2.85 - $3.05 (1) Our outlook does not include provisions for proposed tax law changes, future asset impairments or for pending legal matters, other than future legal amounts that are probable and estimable. Further, due to their nature, certain income and expense items, such as certain investments, derivative and foreign currency transaction gains or losses, cannot be accurately forecast. Accordingly, we only include such items in our financial outlook to the extent they are reasonably certain. Our outlook includes the impact of any pending business combinations to the extent they are expected to close in the upcoming quarter. Actual results may differ materially from the outlook. (2) Our guidance for diluted EPS attributable to other items for the first quarter of fiscal 2025 is primarily related to the requirement to capitalize research and development expenditures under U.S. Feder
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.